» Articles » PMID: 23619762

Revisiting Hyper- and Hypo-androgenism by Tandem Mass Spectrometry

Overview
Publisher Springer
Specialty Endocrinology
Date 2013 Apr 27
PMID 23619762
Citations 8
Authors
Affiliations
Soon will be listed here.
Abstract

Modern endocrinology is living a critical age of transition as far as laboratory testing and biochemical diagnosis are concerned. Novel liquid chromatography-tandem mass spectrometry (LC-MS/MS) assays for steroid measurement in biological fluids have abundantly demonstrated their analytical superiority over immunometric platforms that until now have dominated the world of steroid hormones determination in clinical laboratories. One of the most useful applications of LC-MS/MS is in the hypogonadism and hyperandrogenism field: LC-MS/MS has proved particularly suitable for the detection of low levels of testosterone typical of women and children, and in general more reliable in accurately determining hypogonadal male levels. This technique also offers increased informative power by allowing multi-analytical profiles that give a more comprehensive picture of the overall hormonal asset. Several LC-MS/MS methods for testosterone have been published in the last decade, some of them included other androgen or more comprehensive steroid profiles. LC-MS/MS offers the concrete possibility of achieving a definitive standardization of testosterone measurements and the generation of widely accepted reference intervals, that will set the basis for a consensus on the diagnostic value of biochemical testing. The present review is aimed at summarizing technological advancements in androgen measurements in serum and saliva. We also provide a picture of the state of advancement of standardization of testosterone assays, of the redefinition of androgen reference intervals by novel assays and of studies using LC-MS/MS for the characterization and diagnosis of female hyperandrogenism and male hypogonadism.

Citing Articles

Normative range of various serum hormonal parameters among Indian women of reproductive age: ICMR-PCOS task force study outcome.

Ganie M, Chowdhury S, Suri V, Joshi B, Bhattacharya P, Agrawal S Lancet Reg Health Southeast Asia. 2023; 15:100226.

PMID: 37614351 PMC: 10442974. DOI: 10.1016/j.lansea.2023.100226.


Androgens in women: Establishing reference intervals for dehydroepiandrostenedione sulphate and androstenedione on the Roche Cobas.

Bokulic A, Zec I, Marijancevic D, Goreta S Biochem Med (Zagreb). 2023; 33(2):020706.

PMID: 37324111 PMC: 10231767. DOI: 10.11613/BM.2023.020706.


GWAS of allometric body-shape indices in UK Biobank identifies loci suggesting associations with morphogenesis, organogenesis, adrenal cell renewal and cancer.

Christakoudi S, Evangelou E, Riboli E, Tsilidis K Sci Rep. 2021; 11(1):10688.

PMID: 34021172 PMC: 8139988. DOI: 10.1038/s41598-021-89176-6.


The Variability and Determinants of Testosterone Measurements in Children: A Critical Review.

Li J, Goodman X, Cho J, Holditch-Davis D Biol Res Nurs. 2021; 23(4):646-657.

PMID: 34000839 PMC: 8726425. DOI: 10.1177/10998004211017323.


Causes, patterns and severity of androgen excess in 487 consecutively recruited pre- and post-pubertal children.

Idkowiak J, Elhassan Y, Mannion P, Smith K, Webster R, Saraff V Eur J Endocrinol. 2018; 180(3):213-221.

PMID: 30566905 PMC: 6365673. DOI: 10.1530/EJE-18-0854.


References
1.
Owen L, Keevil B . Testosterone measurement by liquid chromatography tandem mass spectrometry: the importance of internal standard choice. Ann Clin Biochem. 2012; 49(Pt 6):600-2. DOI: 10.1258/acb.2012.012037. View

2.
Lakshman K, Kaplan B, Travison T, Basaria S, Knapp P, Singh A . The effects of injected testosterone dose and age on the conversion of testosterone to estradiol and dihydrotestosterone in young and older men. J Clin Endocrinol Metab. 2010; 95(8):3955-64. PMC: 2913038. DOI: 10.1210/jc.2010-0102. View

3.
Miller W, Auchus R . The molecular biology, biochemistry, and physiology of human steroidogenesis and its disorders. Endocr Rev. 2010; 32(1):81-151. PMC: 3365799. DOI: 10.1210/er.2010-0013. View

4.
Shackleton C . Clinical steroid mass spectrometry: a 45-year history culminating in HPLC-MS/MS becoming an essential tool for patient diagnosis. J Steroid Biochem Mol Biol. 2010; 121(3-5):481-90. DOI: 10.1016/j.jsbmb.2010.02.017. View

5.
Kushnir M, Rockwood A, Roberts W, Yue B, Bergquist J, Meikle A . Liquid chromatography tandem mass spectrometry for analysis of steroids in clinical laboratories. Clin Biochem. 2010; 44(1):77-88. DOI: 10.1016/j.clinbiochem.2010.07.008. View